In xenograft tumorigenesis with E3LZ10.7 and AsPC-1 cells, both of which express higher levels of FGF19, the knockdown of FGF19 decreased tumor volumes and tumor-initiating cells (Figure 5, A–C, and Supplemental Figure 3, E and F). This evidence concerns the gene FGF19 and neoplasm.